Anavex Life Sciences Corp (AVXL)
followers
ยท
Follow
1 like
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
CEO: | Christopher U. Missling |
Employees: | 40 |
Web site: | anavex.com |
630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
844-689-3939
|
-
Formally known as:
- Anvx Lf Scn Corp
Date | Ratio |
---|---|
2006-06-13 | 6:1 |
2015-10-07 | 1:4 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Anavex Life Sciences Corp. engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the. treatment of Alzheimer's disease. The company's drug candidate also comprises ANaVEX 3-71 which is. in Phase I clinical. trial for frontotemporal dementia and other dementia indications.
Please log in first to see chart